Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration – World Pharma Today

Close

[adrotate banner="2"]

Search

Home
News
Articles
Press Releases
Interviews
White Papers
Industry Reports
BioPharma
More

World Pharma Today Magazine for the C-level Pharma Executives

Home
News
Articles
Press Releases
Interviews
White Papers
Industry Reports
BioPharma
More